1. Panicek DM, Heitzman ER, Randall PA, et al. The continuum of pulmonary developmental anomalies[J]. Radiographics, 1987,7(4):747-772. DOI: 10.1148/radiographics.7.4.3448653.
2. Bush A, Hogg J, Chitty LS. Cystic lung lesions-prenatal diagnosis and management[J]. Prenat Diagn, 2008,28(7):604-611. DOI: 10.1002/pd.2039.
3. Swarr DT, Peranteau WH, Pogoriler J, et al. Novel molecular and phenotypic insights into congenital lung malformations[J]. Am J Respir Crit Care Med, 2018,197(10):1328-1339. DOI: 10.1164/rccm.201706-1243OC.
4. Adzick NS, Harrison MR, Crombleholme TM, et al. Fetal lung lesions: management and outcome[J]. Am J Obstet Gynecol, 1998,179(4):884-889. DOI: 10.1016/s0002-9378(98)70183-8.
5. Crombleholme TM, Coleman B, Hedrick H, et al. Cystic adenomatoid malformation volume ratio predicts outcome in prenatally diagnosed cystic adenomatoid malformation of the lung[J]. J Pediatr Surg, 2002,37(3):331-338. DOI: 10.1053/jpsu.2002.30832.
6. Kunisaki SM, Barnewolt CE, Estroff JA, et al. Large fetal congenital cystic adenomatoid malformations: growth trends and patient survival[J]. J Pediatr Surg, 2007,42(2):404-410. DOI: 10.1016/j.jpedsurg.2006.10.014.
7. Karlsson M, Conner P, Ehren H, et al. The natural history of prenatally diagnosed congenital pulmonary airway malformations and bronchopulmonary sequestrations[J]. J Pediatr Surg, 2022,57(10):282-287. DOI: 10.1016/j.jpedsurg. 2022.03.021.
8. Peranteau WH, Boelig MM, Khalek N, et al. Effect of single and multiple courses of maternal betamethasone on prenatal congenital lung lesion growth and fetal survival[J]. J Pediatr Surg, 2016,51(1):28-32. DOI: 10.1016/j.jpedsurg.2015.10.018.
9. Curran PF, Jelin EB, Rand L, et al. Prenatal steroids for microcystic congenital cystic adenomatoid malformations[J]. J Pediatr Surg, 2010,45(1):145-150. DOI: 10.1016/j.jpedsurg. 2009.10.025.
10. Litwińska M, Litwińska E, Janiak K, et al. Thoracoamniotic shunts in macrocystic lung lesions: case series and review of the literature[J]. Fetal Diagn Ther, 2017,41(3):179-183. DOI: 10.1159/000448095.
11. Peranteau WH, Adzick NS, Boelig MM, et al. Thoracoamniotic shunts for the management of fetal lung lesions and pleural effusions: a single-institution review and predictors of survival in 75 cases[J]. J Pediatr Surg, 2015,50(2):301-305. DOI: 10.1016/j.jpedsurg.2014.11.019.
12. Ong SS, Chan SY, Ewer AK, et al. Laser ablation of foetal microcystic lung lesion: successful outcome and rationale for its use[J]. Fetal Diagn Ther, 2006,21(5):471-474. DOI: 10.1159/000093891.
13. Ruano R, da Silva MM, Salustiano EM, et al. Percutaneous laser ablation under ultrasound guidance for fetal hyperechogenic microcystic lung lesions with hydrops: a single center cohort and a literature review[J]. Prenat Diagn, 2012,32(12):1127-1132. DOI: 10.1002/pd.3969.
14. Bermúdez C, Pérez-Wulff J, Arcadipane M, et al. Percutaneous fetal sclerotherapy for congenital cystic adenomatoid malformation of the lung[J]. Fetal Diagn Ther, 2008,24(3):237-240. DOI: 10.1159/000151345.
15. Hellmund A, Berg C, Geipel A, et al. Prenatal diagnosis and evaluation of sonographic predictors for intervention and adverse outcome in congenital pulmonary airway malformation[J]. PLoS One, 2016,11(3):e0150474. DOI: 10.1371/journal.pone.0150474.
16. Knox EM, Kilby MD, Martin WL, et al. In-utero pulmonary drainage in the management of primary hydrothorax and congenital cystic lung lesion: a systematic review[J]. Ultrasound Obstet Gynecol, 2006,28(5):726-734. DOI: 10.1002/uog.3812.